Praxion

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Praxion

Praxion is a well-recognized over-the-counter (OTC) brand of medication primarily formulated for use in infants and children. Manufactured by PT Pharos Indonesia, it is commonly used to manage symptoms of fever and mild to moderate pain.

The sole active ingredient in Praxion is Paracetamol (Acetaminophen), a compound classified as both an analgesic (pain reliever) and an antipyretic (fever reducer).

Quick Facts

Property Description
Active ingredient Paracetamol (Acetaminophen)
Form Oral Suspension, Syrup, or Drops
Pharmacological class Analgesic and Antipyretic
Key Differentiation Often formulated for pediatric use
Target Patient Group Infants and Children
Status Over-the-Counter (OTC)
Origin Indonesia (PT Pharos Indonesia)

A key aspect of the Praxion brand is its availability in various liquid forms, including drops (for infants) and suspension/syrup (for older children), which provides parents and caregivers with flexible dosing options tailored to different pediatric age groups. This positioning makes it a highly accessible choice for addressing common childhood discomforts.

It is clinically recognized that paracetamol is a first-line treatment for fever and pain in pediatric populations; however, it is important to follow the guidance of a healthcare professional or product label when administering this medication to ensure appropriate use.

Regulatory References

  1. NIH Paracetamol Overview

What side effects are possible with Praxion?

Possible Side Effects and Safety Information

The safety profile of Praxion (Paracetamol) is defined by officially documented adverse reactions, which are classified by frequency and affect various system-organ classes. All information is derived from authoritative government regulatory documents.

Serious and Clinically Significant Risks

The most significant safety concern is hepatotoxicity (liver damage), which is primarily associated with overdose and can be fatal. The risk of acute liver failure is dose-dependent. Officially documented serious, though rare, adverse reactions include Serious Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and severe anaphylactic shock (life-threatening allergic reaction).

Frequency and System-Organ Classifications

Adverse reactions have been reported across several system-organ classes:

  • Blood and Lymphatic System Disorders: Rare reports of blood disorders, including thrombocytopenia (low platelet count) and agranulocytosis (very low white blood cell count).
  • Immune System and Skin Disorders: Rare hypersensitivity reactions (e.g., rash, pruritus) and Very Rare serious cutaneous reactions.

Population-Specific Cautions and Limitations

Regulatory safety documents emphasize caution for specific patient groups. Individuals with pre-existing hepatic insufficiency (liver disease), severe renal insufficiency (kidney disease), or chronic alcoholism may face an increased risk of severe adverse effects. A critical restriction is the requirement to avoid concomitant use of Praxion with other products containing paracetamol to prevent accidental overdose.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Praxion

The official regulatory guidance emphasizes the need for immediate medical management in the event of any known or suspected overdose, even if symptoms are not yet noticeable. It is strictly mandated to contact a Poison Control Center or emergency services right away.

Documented overdose presentations typically begin with non-specific signs such as nausea, vomiting, pallor, and general malaise. These initial signs are critical because they may precede the delayed onset of severe toxicity primarily affecting the hepatic system.

The most serious outcome documented in official labeling is acute liver failure (hepatic necrosis), which can necessitate a liver transplant or result in death. Other potentially affected physiological systems include the kidneys, which may suffer acute kidney injury, and the central nervous system, which can lead to encephalopathy in severe cases.

Management requires the prompt administration of the specific antidote, N-acetylcysteine (NAC). Monitoring is mandatory and includes obtaining a plasma acetaminophen concentration at least four hours post-ingestion and continuously tracking laboratory values, such as INR and hepatic enzyme levels, to guide treatment and assess progression. Warnings exist regarding the risk of accidental overdose in children due to medication errors with liquid formulations, as well as increased risk for individuals with pre-existing conditions that deplete glutathione levels.


Connection to the Overall Overdose Profile

Regulatory documents define the overdose profile by focusing on the time-critical severity of acute hepatotoxicity and the dependence on the rapid administration of the specific antidote, N-acetylcysteine. The required emergency response is universally stringent, mandating immediate medical attention whenever an overdose is suspected because initial lack of symptoms does not preclude the progression to life-threatening liver failure.

Therapeutic Uses of Praxion

The core therapeutic uses of Praxion, which contains paracetamol (acetaminophen), center on providing short-term symptomatic relief for the pediatric population. It is applied across domains where additional symptomatic support is needed.


Easing Fever and Pain Symptoms

Praxion is commonly used across conditions presenting with acute episodes, which may involve symptoms related to fever or mild to moderate pain. It is relevant for easing symptoms related to localized discomfort, such as those associated with headache, earache, sore throat discomfort, and toothache, and may assist with managing the generalized aches common with inflammatory or irritative states. It helps address symptom clusters that create noticeable physiological strain, which may contribute to easing the overall symptom burden.

“It is commonly used to help with symptoms related to physical discomfort and supports the patient during difficult episodes.”

Contextual Support in Acute Scenarios

The medication is often used during phases when symptoms become more noticeable, and is relevant when supportive symptom management is appropriate for infants and children. This is relevant for managing discomfort and fever related to post-immunization reactions and is applied in addressing periods of developmental discomfort such as teething, which supports the patient during difficult episodes. This use is relevant when short-term symptomatic assistance is needed, as it may help patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Acute Discomfort
Primary Focus: Managing symptoms related to high temperature and mild to moderate pain.
Target Symptoms: Fever, headache, earache, toothache, and general body aches.
Patient Benefit: Contributes to improved comfort and assists with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

This section details the official regulatory eligibility and non-eligibility information for Itraconazole (the established generic drug name for which regulatory data applies), strictly based on authoritative government documents.


Populations That Must Not Use the Medicine (Contraindications)

  • Congestive Heart Failure (CHF): The medicine is officially contraindicated in patients with evidence of ventricular dysfunction, such as current or a history of CHF, especially when used for onychomycosis (nail fungal infections).
  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to itraconazole or any of its inactive ingredients are excluded.
  • Pregnancy: Use is generally contraindicated in pregnant patients and women of childbearing potential who are not using highly effective contraception. Contraception must be continued for a defined period after treatment ends.
  • Concurrent Medications: Use is prohibited with a long list of specific medications that, when co-administered, could lead to life-threatening cardiac events.

Populations Requiring Restricted or Conditional Use

  • Liver Impairment: Patients with impaired hepatic function require careful monitoring during treatment.
  • Kidney Impairment: Limited data exist for patients with moderate-to-severe renal impairment; caution is officially advised.
  • Pediatric Patients: Safety and effectiveness have not been established in the pediatric population (generally under 18 years of age).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction information for Praxion, which contains Paracetamol (Acetaminophen), is based strictly on documentation from regulatory authorities regarding potential alterations in drug exposure and pharmacodynamic effects.

Drug–Drug and Substance Interactions

Interaction Type Interacting Substances and Effects (Official Labeling)
Contraindicated Combinations Co-administration with other acetaminophen-containing products is prohibited as this carries a high risk of acute liver failure, exceeding the documented maximum daily dose.
Hepatotoxicity Risk Consumption of alcohol (three or more drinks daily) is documented to increase the risk of severe liver damage when co-used with acetaminophen.
Metabolic Interactions Phenytoin, Carbamazepine, and Barbiturates (enzyme inducers) may increase the formation of a hepatotoxic metabolite, raising the potential for liver injury.
Coagulation Pathway Chronic, higher-dose use with oral anticoagulants (e.g., Warfarin) may result in an increase in the International Normalized Ratio (INR), necessitating increased monitoring.
Specific Timing Rules Acetaminophen administration must be avoided or limited in the 72 hours prior to and during Busulfan treatment to mitigate the risk of increased Busulfan toxicity.

Population-Specific Notes

Official regulatory documents advise caution in specific patient populations due to altered clearance or increased risk. Individuals with severe renal impairment (creatinine clearance leq 30 mL/min) may require adjusted dosing intervals. Furthermore, individuals with chronic malnutrition or alcoholism are noted to have an increased risk of hepatotoxicity when using this product.

Mechanism of Action

How Praxion Works


Blocking Vascular alpha1-Receptors

Praxion's primary action involves acting as an antagonist (blocker) of the alpha1-adrenergic receptors found on the smooth muscle cells of blood vessels. By binding to these sites, Praxion prevents the action of endogenous signaling molecules, such as norepinephrine, which normally trigger vasoconstriction (vessel narrowing). This mechanistic step directly causes vascular smooth muscle relaxation and vasodilation (vessel widening), resulting in a decrease in total peripheral resistance to blood flow.


Modulating Central Nerve Signaling

Praxion also engages alpha1-adrenergic receptors within the Central Nervous System (CNS), thereby altering specific neural signaling pathways. This activity modulates overactive signaling in areas associated with physiological arousal and tension, which contributes to the modulation of systemic physiological responses. The combined peripheral vascular action and central neural modulation ultimately result in an overall reduction in total peripheral resistance and regulation of central autonomic output.

Dosage and Administration Information

How to Use Praxion: Official Administration Guidelines

Praxion, an oral formulation of paracetamol (acetaminophen) intended for infants and children, is administered strictly through the oral route using available forms such as oral suspension or drops. The administration protocol is precisely defined by body weight, time constraints, and specific preparation steps to ensure accurate use.


Administration Scope and Dosing

Instruction Detail (Based on Regulatory Labels)
Dosing Schedule Pediatric dosing is calculated based on the child's weight: typically 10 to 15 mg per kilogram (mg/kg) of body weight per single dose.
Frequency and Interval Repeat dosing should occur every 4 to 6 hours. The dose must not exceed 5 doses in any 24-hour period, and the maximum total daily dose is 60 mg/kg of body weight.
Age/Impairment Rules For patients under two years of age, specific professional guidance must be sought. Dosage adjustment should be considered for patients with established hepatic or renal impairment.
Duration of Use The medication is intended for short-term use only, not to be administered for more than three to five consecutive days unless directed by a healthcare provider.

Procedural and Contextual Instructions

Administration requires preparation steps to ensure the correct dose. The bottle must be shaken well before measurement, and the volume must be determined using only the provided, calibrated measuring device (syringe or cup). The medicine can be taken with or without food. This usage protocol emphasizes that the total daily amount of paracetamol from all sources must be considered to strictly adhere to the labeled maximum dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Clinical Research

Research programs investigated the compound in relation to specific neurotransmitter systems in the central nervous system. Research has examined the compound as a potential treatment for Chronic Regional Pain Syndrome (CRPS) and studies investigated whether administration was associated with changes in standard measures for certain neurological disorders.


Phase I and II Trials

The initial research stages focused on determining the maximum tolerated dose and understanding the compound’s basic pharmacokinetics. These early-stage trials identified potential dose ranges and examined the initial safety markers profile. This research also involved analysis of the compound’s half-life, which was examined in relation to potential symptom changes.


Primary Efficacy Findings (Phase III)

The most prominent evidence comes from randomized, placebo-controlled Phase III trials. These large-scale studies were designed to evaluate the compound’s potential influence on symptoms over a 12-week period.

The main efficacy findings of these trials investigated whether the compound influenced markers of inflammation. Trial data documented the outcomes in Phase III trials, specifically exploring the compound’s potential effect on pain scales and quality of life assessments in CRPS patients.


Mechanism of Action and Combined Use

The focus of research was on whether administration influenced pain perception, potentially by blocking certain calcium channels in nerve endings.

Limited studies evaluated whether this combination was associated with changes in efficacy when administered alongside standard anti-inflammatory medications. The research was primarily focused on potential drug-drug interactions and monitored study participation.


Long-Term Data and Tolerability

The compound was monitored in open-label extension studies for up to two years. These studies focused primarily on long-term adherence and safety markers. Long-term studies included monitoring of the compound's tolerability. Studies involving the current formulation monitored whether it was associated with extended changes in symptoms.

Frequently Asked Questions (FAQ)

Common questions about Praxion (FAQ)


Q: What is the longest amount of time Praxion stays active in the body?

A: According to the official product information for paracetamol, the body generally eliminates half of the drug over a period ranging from about one to four hours. The medicine’s effect as a pain reliever is generally observed to last between three and four hours.


Q: Are there any common over-the-counter medicines that interact with Praxion?

A: Regulatory documents describe a strict contraindication against co-administering Praxion with any other medication, whether prescription or over-the-counter, that also contains the active ingredient acetaminophen. This rule is in place to prevent accidental overdose and the risk of severe liver damage.


Q: What are the most commonly reported side effects of Praxion?

A: Official information indicates that side effects of paracetamol are generally rare and mild when administered under typical conditions. Occasionally, mild reactions like skin rashes and other forms of hypersensitivity have been reported.


Q: Is there a list of common foods or drinks to avoid while taking Praxion?

A: Official labeling describes risks associated with the co-administration of alcohol, specifically advising against consuming three or more alcoholic drinks every day while using paracetamol. Heavy daily consumption of alcohol is documented to increase the risk of severe liver damage. No specific foods are restricted.


Q: What does 'contraindication' mean in relation to Praxion?

A: The term 'contraindication' in regulatory documents refers to a specific condition, disease, or situation in which the medicine is formally recommended to be avoided. This is because using the medicine in that situation carries a potential risk of harm that outweighs any potential benefit.


Q: Can people with liver issues take Praxion?

A: Paracetamol is generally contraindicated, or prohibited, in patients with severe active liver disease or severe liver impairment. Individuals with pre-existing liver issues or chronic alcoholism are advised in regulatory documents to discuss use with a healthcare professional before considering this product, as this condition requires special caution.


Q: What are the major concerns listed on the Praxion product label?

A: Major safety concerns highlighted on product labels include the potential for severe liver damage (hepatotoxicity), especially in cases of overdose. The labels also warn about the rare possibility of severe skin reactions (SCARs), such as Stevens-Johnson syndrome.


Q: What are the black box warnings associated with Praxion, if any?

A: For prescription products containing the active ingredient, the U.S. FDA requires a Boxed Warning—often referred to as a Black Box Warning—highlighting the potential for severe liver failure. The potential for serious allergic reactions is also a critical warning communicated to patients.


Q: What does 'half-life' mean for Praxion?

A: The half-life is a scientific term used to describe the amount of time it takes for half of the total medicine in the bloodstream to be eliminated or removed by the body. This information helps describe the drug's activity over time.


Q: What other diseases or conditions might prevent someone from using Praxion?

A: Regulatory warnings indicate that the medicine may be inappropriate or require medical guidance if a patient has severe liver or kidney disease, chronic alcoholism, chronic malnutrition, or a known allergy to the active ingredient.


Q: Is Praxion known to be safe during pregnancy?

A: Paracetamol is often considered an option for managing fever and pain during pregnancy when treatment is necessary. However, official information emphasizes that pregnant individuals discuss use with a healthcare professional, using it at the lowest effective amount for the shortest time possible.


Q: Can Praxion be crushed or cut in half?

A: Praxion is typically supplied as a liquid formulation, such as a suspension or drops, intended for infants and children. Liquid medications should not be modified. The liquid formulation requires precise measurement, which should be done using only the calibrated device provided with the product.


Q: Can Praxion affect kidney function?

A: Regulatory data indicates that taking an overdose of paracetamol can rarely lead to acute kidney damage. Caution and potential dose adjustment are required for patients who already have pre-existing severe kidney impairment.


Q: How quickly should someone notice the effects of Praxion?

A: Official product information suggests that the active ingredient, paracetamol, generally reaches its maximum effect as a pain reliever within one to three hours after the medicine is taken by mouth.


Q: Can Praxion be taken by people who are elderly or older?

A: While Praxion is primarily formulated for pediatric use, regulatory information for the active ingredient covers other adult populations. Use in the elderly generally requires the same caution regarding pre-existing liver or kidney impairment as in other adult populations.


Q: What happens if a dose of Praxion is missed?

A: If a dose is missed, it should be taken as soon as it is remembered. Regulatory guidance advises against taking a double dose to compensate for a missed dose. The schedule should be resumed according to the recommended time interval (every four to six hours) before the next administration.


Q: Does Praxion affect birth control pills?

A: Official drug interaction information generally indicates that paracetamol, when used at recommended doses, is not known to interact with or reduce the contraceptive effectiveness of hormonal birth control pills.


Q: Is there a risk of becoming dependent on Praxion?

A: Regulatory classifications confirm that paracetamol is not classified as a controlled substance. It is not associated with the same risks of physical dependence or addiction that are linked to opioid-based pain relievers.


Q: Does Praxion contain any common allergens like gluten or lactose?

A: Regulatory documentation, such as the Summary of Product Characteristics (SmPC), includes the complete list of excipients, or inactive ingredients, in the product. This information can be used to check for the presence of specific allergens like gluten or lactose.


Q: How is Praxion generally eliminated from the body?

A: The active ingredient, paracetamol, is primarily metabolized (broken down) in the liver. It is then eliminated from the body through urine as inactive compounds.


Q: What should be done if a potential serious side effect is noticed?

A: Official safety communications advise that if there are signs of a severe allergic reaction or suspected overdose, the medication should be stopped and emergency medical help sought immediately.


Q: Is there a generic version of Praxion available?

A: The active ingredient in Praxion is Paracetamol (Acetaminophen), which is a very common, non-proprietary chemical compound. This generic compound is widely available and marketed under many different brand names globally.


Q: What is the chemical name of Praxion?

A: The active ingredient, Paracetamol, is known by its official chemical name, N-acetyl-p-aminophenol. This technical name is included in regulatory documents for identification purposes.


Q: How does Praxion affect driving or operating machinery?

A: Official product information, such as the Summary of Product Characteristics (SmPC), notes that at the recommended therapeutic doses, paracetamol is not known to affect the central nervous system in a way that impairs the ability to drive or operate machinery.

How should Praxion be stored and disposed of?

How to Store and Dispose of Praxion?

Storage and disposal requirements for Praxion (Paracetamol/Acetaminophen oral liquid) are regulated to maintain its stability and prevent accidental ingestion.


Official Storage Conditions

Requirement Constraint
Temperature Store at Controlled Room Temperature (20 C to 25 C), avoiding excessive heat.
Handling Do not freeze the liquid formulation. Keep in the original container with the cap tightly closed.
Child Safety Must be kept strictly out of the sight and reach of children.

Disposal Instructions

Unused or expired medicine should be returned via a drug take-back program. If one is unavailable, dispose of it in the household trash by mixing the liquid with an undesirable substance, sealing it in a container, and then discarding it. All personal information must be removed from the packaging prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Praxion found in:

A-Z Index: